2022 annual financial data
Supernus Pharmaceuticals 2022 Operating margin
Supernus Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was 6.91%.
Operating income was 46,124,000 USD and net income was 60,711,000 USD.
Operating cash flow was 116,826,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 667,238,000 USD
- Operating income
- 46,124,000 USD
- Net income
- 60,711,000 USD
- Operating cash flow
- 116,826,000 USD